Anna Cheng
MD Student
Boston University Chobanian & Avedisian School of Medicine



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Weinstein ZM, Magane KM, Lodi S, Ventura AS, Bazzi AR, Blodgett J, Fielman S, Davoust M, Shea MG, Chen CA, Cheng A, Theisen J, Blakemore S, Saitz R. The Impact of COVID-19 on Substance Use and Related Consequences among Patients in Office-Based Opioid Use Disorder Treatment. J Addict Med. 2024 Aug 05.View Related Profiles. PMID: 39101572
     
  2. Wong G, Venkatesha V, Montebello ME, Masoe A, Cheng K, Cook H, Puszka B, Cheng A. Oral health status and oral health-related quality of life: a cross-sectional study of clients in an Australian opioid treatment program. Aust J Prim Health. 2024 Aug; 30. PMID: 39213387
     
  3. Davoust M, Bazzi AR, Blakemore S, Blodgett J, Cheng A, Fielman S, Magane KM, Theisen J, Saitz R, Ventura AS, Weinstein ZM. Patient and Clinician Experiences with the Implementation of Telemedicine and Related Adaptations in Office-Based Buprenorphine Treatment During the COVID-19 Pandemic: A Qualitative Study. Res Sq. 2024 Apr 22.View Related Profiles. PMID: 38746460; PMCID: PMC11092823; DOI: 10.21203/rs.3.rs-4272282/v1;
     
  4. Cheng A, Badolato R, Segoshi A, McDonald R, Malone M, Vasudevan K, Badiei B, Sugarman A, Macdonald R, Mangat J, Giftos J, Lee JD, Tofighi B. Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study. Addict Sci Clin Pract. 2022 Jan 29; 17(1):4. PMID: 35093164; PMCID: PMC8800291; DOI: 10.1186/s13722-022-00288-4;
     
  5. Lin NU, Pegram M, Sahebjam S, Ibrahim N, Fung A, Cheng A, Nicholas A, Kirschbrown W, Kumthekar P. Reply to J. Wei et al. J Clin Oncol. 2021 Dec 20; 39(36):4127-4128. PMID: 34637335
     
  6. Waddell EN, Springer SA, Marsch LA, Farabee D, Schwartz RP, Nyaku A, Reeves R, Goldfeld K, McDonald RD, Malone M, Cheng A, Saunders EC, Monico L, Gryczynski J, Bell K, Harding K, Violette S, Groblewski T, Martin W, Talon K, Beckwith N, Suchocki A, Torralva R, Wisdom JP, Lee JD. Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS). J Subst Abuse Treat. 2021 Sep; 128:108389. PMID: 33865691; PMCID: PMC8384640; DOI: 10.1016/j.jsat.2021.108389;
     
  7. Tsou HH, Yang HC, Hsiao CF, Hsiung CA, Liu TW, Chuang MH, Wu HY, Hsu YT, Tsui CW, Chen PJ, Cheng AL, Hsu C. Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection. J Formos Med Assoc. 2020 Jan; 119(1 Pt 2):335-344. PMID: 31235201
     
  8. Abou-Alfa GK, Meyer T, Cheng AL, El-Khoueiry AB, Rimassa L, Ryoo BY, Cicin I, Merle P, Chen Y, Park JW, Blanc JF, Bolondi L, Klümpen HJ, Chan SL, Zagonel V, Pressiani T, Ryu MH, Venook AP, Hessel C, Borgman-Hagey AE, Schwab G, Kelley RK. Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma. N Engl J Med. 2018 Jul 05; 379(1):54-63. PMID: 29972759
     
  9. Zhu AX, Finn RS, Edeline J, Cattan S, Ogasawara S, Palmer D, Verslype C, Zagonel V, Fartoux L, Vogel A, Sarker D, Verset G, Chan SL, Knox J, Daniele B, Webber AL, Ebbinghaus SW, Ma J, Siegel AB, Cheng AL, Kudo M. Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial. Lancet Oncol. 2018 Jul; 19(7):940-952. PMID: 29875066
     
  10. Kuo HY, Lin ZZ, Kuo R, Shau WY, Lai CL, Yang YY, Shao YY, Hsu C, Cheng WF, Cheng AL, Yang JC, Lai MS. The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia. Oncologist. 2015 Sep; 20(9):1051-7. PMID: 26240133
     
Showing 10 of 14 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 14 publications over 9 distinct years, with a maximum of 3 publications in 2024

YearPublications
20101
20111
20142
20151
20182
20191
20212
20221
20243

Contact for Mentoring:

Cheng's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (94) concept(s)
_
Co-Authors
See all (4) people
_
Similar People
See all (60) people
_